The Times newspaper reported on Wednesday that the International Tennis Federation had sent the tenns player three letters informing her about WADA's decision to implement the ban from January 1 this year. Sharapova also received two letters on the same issue from the Women's Tennis Association.
Sharapova had confessed on Monday that she had tested positive for Meldonium, a drug she said she had been taking since 2006 but that was banned by WADA only this year.
Meanwhile, the Kremlin insisted that Sharapova's case was an isolated one even as it expressed regret over the discovery. A spokesperson of the agency insisted that the incident did not reflect Russian sports as a whole and should not be used to tarnish the image of Russian sportspersons in general
Sharapova claimed she began taking Meldonium to address a number of health issues, such as being prone to illness, heart condition and a family history of diabetes.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)